There was also this from the quarterly:
Separate to our clinical trial efforts the Company is also aggressively pursuing multiple other business
development opportunities for the licensing of its SphygmoCor® technology to third-party medical
device companies. We anticipate an announcement regarding the first of these new efforts in the next
4-6 weeks.
There was also this from the quarterly:Separate to our clinical...
Add CDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.3¢ |
Change
-0.002(3.08%) |
Mkt cap ! $18.53M | |||
| Open | High | Low | Value | Volume |
| 6.6¢ | 6.6¢ | 6.2¢ | $17.42K | 275.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 6.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.5¢ | 300000 | 1 |
View Market Depth
| Last trade - 12.56pm 11/07/2024 (20 minute delay) ? |
| CDX (ASX) Chart |